| Indicators | Browse All

ProShares UltraShort Nasdaq Biotechnology (BIS)

Trading--Inverse Equity | Exchange Traded Fund | NasdaqGM
11.46 USD -0.51 (-4.256%) ⇩ (Oct. 15, 2026, 4 p.m. EDT)

Short-term:★☆☆☆☆Long-term:⯪☆☆☆☆Dividends:★★⯪☆☆
Hot Take ↕ | Oct. 10, 2026, 11:17 a.m. EDT

This instrument is a leveraged inverse ETF tracking the Nasdaq Biotechnology sector, which has suffered a brutal multi-year decline. The underlying index has lost over 90% of its value in the last nine years, with the last three years showing consecutive negative returns. While the current price is hovering near its 52-week low, the momentum remains deeply bearish, with the price still down roughly 26% from its 200-day average. The statistical forecast model predicts a further 5% drop over the next 45 days, aligning with the persistent downtrend. Despite the 5.5% dividend yield, this payout is likely a result of capital erosion rather than sustainable cash flow, as the underlying assets are depreciating rapidly. The options market confirms this pessimism, with traders buying significant protection far out-of-the-money while offering almost no upside exposure. This is a high-risk speculative vehicle for betting on a biotech crash, not a long-term investment.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.053384
MSTL0.138492
AutoARIMA0.138627
AutoETS0.138770

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 45%
H-stat 1.08
Ljung-Box p 0.000
Jarque-Bera p 0.120
Excess Kurtosis -0.58

As of Oct. 10, 2026, 11:17 a.m. EDT: Speculators are positioning for continued downside with heavy put open interest concentrated significantly out-of-the-money (OTM) at strikes 16, 20, and 21 across multiple expirations. Call activity is negligible and skewed toward OTM strikes, indicating a lack of bullish conviction. Implied volatility is extremely low for puts (near zero ATM), suggesting the market expects minimal immediate movement but maintains a structural bearish bias via the heavy tail of OTM protection.


Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
1.21% 4.02% 3.80% 2.41%
Dividend History
Date Dividend Yield %
2026-09-23 0.139 1.208696
2026-06-24 0.137 0.921318
2026-03-25 0.138 0.748373
2025-12-24 0.206 1.143174
2025-09-24 0.308 1.134021
2025-06-25 0.216 0.611898
2025-03-26 0.266 0.750141
2024-12-23 0.412 1.162528
2024-09-25 0.304 0.979381
2024-06-26 0.322 0.975167
2024-03-20 0.318 0.893258
2023-12-20 0.352 0.866568
2023-09-20 0.238 0.544872
2023-06-21 0.042 0.106599
2020-03-25 0.208 0.161994
2019-12-24 0.328 0.320312
2019-09-25 0.648 0.425197
2019-06-25 0.768 0.541761
2019-03-20 0.512 0.390720
2018-12-26 0.544 0.285355
2018-09-26 0.144 0.112711
Additional Data
trailingAnnualDividendRate 0.0
trailingAnnualDividendYield 0.0
dividendYield 5.53

Info Dump

Attribute Value
All Time High 13,699.2
All Time Low 10.51
Ask 13.38
Ask Size 1
Average Daily Volume10 Day 10,080
Average Daily Volume3 Month 8,329
Average Volume 8,329
Average Volume10Days 10,080
Beta3 Year -1.16
Bid 13.16
Bid Size 1
Category Trading--Inverse Equity
Crypto Tradeable 0
Currency USD
Custom Price Alert Confidence HIGH
Day High 11.55
Day Low 11.34
Display Name UltraShort Nasdaq Biotechnology
Dividend Yield 5.53
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 11.6124
Fifty Day Average Change -0.15190029
Fifty Day Average Change Percent -0.01308087
Fifty Two Week Change Percent -50.560833
Fifty Two Week High 23.7
Fifty Two Week High Change -12.239501
Fifty Two Week High Change Percent -0.5164346
Fifty Two Week Low 10.51
Fifty Two Week Low Change 0.95049953
Fifty Two Week Low Change Percent 0.090437636
Fifty Two Week Range 10.51 - 23.7
First Trade Date Milliseconds 1,270,819,800,000
Five Year Average Return -0.1861689
Full Exchange Name NasdaqGM
Fullday Change -0.5095005
Fullday Change Percent -4.253103
Fullday Price 11.4605
Fund Family ProShares
Fund Inception Date 1,270,512,000
Gmt Off Set Milliseconds -14,400,000
Has Pre Post Market Data 1
Language en-US
Legal Type Exchange Traded Fund
Long Business Summary The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Long Name ProShares UltraShort Nasdaq Biotechnology
Market us_market
Market State PRE
Max Age 86,400
Message Board Id finmb_100661536
Nav Price 11.94
Net Assets 1,850,591.0
Net Expense Ratio 0.95
Open 11.445
Previous Close 11.97
Price Hint 2
Quote Source Name Nasdaq Real Time Price
Quote Type ETF
Region US
Regular Market Change -0.5095005
Regular Market Change Percent -4.256479
Regular Market Day High 11.55
Regular Market Day Low 11.34
Regular Market Day Range 11.34 - 11.55
Regular Market Open 11.445
Regular Market Previous Close 11.97
Regular Market Price 11.4605
Regular Market Time 1,792,094,400
Regular Market Volume 13,433
Short Name ProShares UltraShort Nasdaq Bio
Source Interval 15
Symbol BIS
Three Year Average Return -0.33366853
Total Assets 1,850,591
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Peg Ratio None
Trailing Three Month Nav Returns -16.74861
Trailing Three Month Returns -16.74861
Triggerable 1
Two Hundred Day Average 15.455
Two Hundred Day Average Change -3.9945002
Two Hundred Day Average Change Percent -0.25846004
Type Disp ETF
Volume 13,433
Yield 0.0553
Ytd Return -39.25485